Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2013; 19(10): 1618-1624
Published online Mar 14, 2013. doi: 10.3748/wjg.v19.i10.1618
Published online Mar 14, 2013. doi: 10.3748/wjg.v19.i10.1618
Table 4 Gastrointestinal Symptom Rating Scale before therapy in Child A and Child B groups and before and after therapy (mean ± SE)
| Child A | Child B | P value | Before | After | P value | |
| GSRS score | 1.5 ± 0.1 | 1.7 ± 0.3 | NS | 1.5 ± 0.1 | 1.6 ± 0.1 | NS |
| Reflux | 1.4 ± 0.1 | 1.4 ± 0.3 | NS | 1.4 ± 0.1 | 1.4 ± 0.2 | NS |
| Abdominal pain | 1.3 ± 0.1 | 1.6 ± 0.2 | NS | 1.4 ± 0.1 | 1.6 ± 1.2 | NS |
| Indigestion | 1.4 ± 0.1 | 1.9 ± 0.3 | NS | 1.6 ± 0.1 | 1.6 ± 0.1 | NS |
| Diarrhea | 1.3 ± 0.1 | 1.5 ± 0.2 | NS | 1.4 ± 0.1 | 1.6 ± 0.1 | NS |
| Constipation | 1.8 ± 0.2 | 2.2 ± 0.4 | NS | 1.9 ± 0.2 | 1.9 ± 0.2 | NS |
- Citation: Kobayashi M, Kinekawa F, Matsuda K, Fujihara S, Nishiyama N, Nomura T, Tani J, Miyoshi H, Kobara H, Deguchi A, Yoneyama H, Mori H, Masaki T. Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function. World J Gastroenterol 2013; 19(10): 1618-1624
- URL: https://www.wjgnet.com/1007-9327/full/v19/i10/1618.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i10.1618